1.annaadria@yahoo.com (AZ); Kuwait Cancer Control Center, Kuwait (SaB).
Myelodysplatic syndrome (MDS) with an isolated 5q deletion (5q-syndrome), that may arise de novo or may be therapy-related is recognized as a distinct entity by the WHO classification. While del(5q) thought to contribute to the pathogenesis of myeloid neoplasms, it has also been reported in lymphoblastic leukemia, suggesting a common underlying mechanism.
Soad Al Bahar ; Adriana Zamecnikova
del(5q) in acute lymphoblastic leukemia (ALL)
Atlas Genet Cytogenet Oncol Haematol. 2019-08-01
Online version: http://atlasgeneticsoncology.org/haematological/1768/css/lib/js/lib/jquery-3.5.1.min.js